Health care requires a new approach to venture capital

Scrub Capital is a new venture firm built for early-stage health care startups, powered by clinician insiders and innovators

We offer Founders:

+A brand that communicates good medicine
+Access to insider networks
+Insights into the forefront of medical science and care delivery
+Operating advice from active startup builders
+G2M and recruitment intros with social capital
+Help rising above industry noise

Investment Strategy

We are actively investing as a strategic syndicate member in early-stage, US market focused health care companies. We avoid Class 3 medical devices and therapeutics.

Submit Investment Opportunity

Investment Process

General Partners lead deals and form the Investment Committee while our clinician community offers subject matter expertise and backchannel intelligence.

Sourcing

We source broadly through differentiated GP and clinician networks and are regularly invited into oversubscribed opportunities.

Community Pitch

Live conversation with a curated group of 30+ clinician experts: half pitch, half early advising!

Decision & Syndication

The 3 GP Investment Committee makes the final decision. When interest is high, SPVs are run alongside the fund check.

Initial Screen

30-min GP call to assess quality and thematic fit. Clinician expert curbsides.

Focused Diligence

Two-week assessment of the most important deal considerations, incorporating a smaller group of expert clinicians.

Portfolio Support

Recruiting, clinical and ops guidance, G2M discovery and intros, and amplifying the portfolio through our media platforms.

Sourcing

We source broadly through differentiated GP and clinician networks and are regularly invited into oversubscribed opportunities.

Initial Screen

30-min GP call to assess quality and thematic fit. Clinician expert curbsides.

Community Pitch

Live conversation with a curated group of 30+ clinician experts: half pitch, half early advising!

Focused Diligence

Two-week assessment of the most important deal considerations, incorporating a smaller group of expert clinicians.

Decision & Syndication

The 3 GP Investment Committee makes the final decision. When interest is high, SPVs are run alongside the fund check.

Portfolio Support

Recruiting, clinical and ops guidance, G2M discovery and intros, and amplifying the portfolio through our media platforms.

Fund 1 Investments

Radial

Date:Oct 2025

Round:Series A

Syndicate:

General Catalyst

Interventional psychiatry practice and MSO infrastructure

Scrub Capital Fund 1

Rev Bio

Date:Aug 2025

Round:Seed

Syndicate:

Delta Dental, Boston Harbor Angels

Patented bone adhesive that rapidly sets and withstands high load, potential for many clinical uses

Scrub Capital Fund 1

Clarity Pediatrics

Date:Aug 2025

Round:Series A

Syndicate:

Jackson Square Ventures

Scalable, integrated pediatric specialty care, starting with ADHD

Scrub Capital Fund 1

Spark Spine

Date:June 2025

Round:Seed

Syndicate:

Medical Device Clinician Angel Syndicate

First orthopedic implant with electrical stim for faster healing

Scrub Capital Fund 1

Midi Health

Date:April 2025

Round:Series C

Syndicate:

Advance Venture Partners, McKesson Ventures

Leading virtual clinic for midlife women's care

Scrub Capital Led Growth SPV

Canopy

Date:June 2025

Round:Seed

Syndicate:

Spero Ventures

Real-time wearable staff safety solution

Scrub Capital Fund 1

SuperDial

Date:June 2025

Round:Series A

Syndicate:

SignalFire

Automated outbound calls starting with RCM

Scrub Capital Fund 1

Lifeforce

Date:March 2025

Round:Series A+

Syndicate:

M13, Corazon

Responsible longevity care for the health motivated

Scrub Capital Fund 1

Elion

Date:January 2025

Round:Seed

Syndicate:

NEA, TMV, AlleyCorp

Modern vendor evaluation platform for health systems

Scrub Capital Fund 1

Posterity Health

Date:January 2025

Round:Series A

Syndicate:

Georgetown Capital Partners

Virtual clinic for male reproductive health and infertility

Scrub Capital Fund 1

Oshi Health

Date:December 2024

Round:Series C

Syndicate:

Oak HC/FT, Flare, Frist Cressey, CVS

Virtual care for chronic GI conditions

Scrub Capital Led Growth SPV

Conceivable Life Sciences

Date:December 2024

Round:Series A

Syndicate:

Artis Ventures, ACME Capital

The first AI-powered, automated IVF lab

Scrub Capital Fund 1

Photon Health

Date:July 2024

Round:Seed Prime

Syndicate:

Flare, Susa, Notation

E-prescribing infrastructure and marketplace

Scrub Capital Fund 1

Meet our 1,000+ member Scrub Collaborative Community

This braintrust of every medical specialty are also entrepreneurs, C-level executives and investors — and they weigh in on every pitch and uniquely assist the portfolio

Clinically diverse: the whole care team and over 40 specialties are represented, including nurses, physicians, psychologists, physical therapists, occupational therapists, and more.

1 in 3

are founders

30%

have held a C-suite role

30%

have held an operational role in startups

20%

have held a formal investor role

Why do clinicians spend their time and capital with us?

Hearts

+Influence where capital is allocated
+Creative outlet
+System-level impact

Minds

+Learn about and debate cutting-edge startups with peers
+VC Fellowships and early-stage investor training program
+Industry luminary speaker series

Wallets

+Low LP minimum to access top tier deals
+Deal sourcing carry share
+Co-investment rights
+Exposure to new career opportunities

Apply to join the Scrub Collaborative

The Scrub Capital Team

Together we bring operator depth, clinical credibility, and narrative reach to every investment decision and our portfolio's journey from first check to exit

Rebecca Mitchell, MD

Managing Partner

Two decades bridging the worlds of medicine, tech, and VC. Built and led industry-leading products used by tens of millions worldwide from 0-1, IPO, and the largest acquisition in health tech history. Former EVP at 500M growth fund.

Jonathan Slotkin, MD

General Partner

Practicing neurosurgeon with over 10 years driving the digital transformation of medicine at the nation's largest integrated health system. Geisinger Chief Medical Officer for Strategy and Growth. Multiple-time medical device cofounder.

Christina Farr

General Partner

One of the most trusted voices and advisors in health technology. Owner of Second Opinion Media, author of "The Storyteller's Advantage". Former health tech lead at OMERS Ventures.

Kevin Foley, MD

Venture Partner, Medical Devices

Medical Device inventor and investor ensuring smart investments and robust portfolio support in this specialized area. Practicing spine surgeon and professor at the University of Tennessee Health Science Center.

The Scrub Capital core team also includes rotating Venture Fellows.